✦ LIBER ✦

Boranophosphate siRNA-aptamer chimeras for tumor-specific downregulation of cancer receptors and modulators

✍ Scribed by Shaw, B. R.; Moussa, L.; Sharaf, M.; Cheek, M.; Dobrikov, M.

Book ID: 121761149
Publisher: Oxford University Press
Year: 2008
Weight: 788 KB
Volume: 52
Category: Article
ISSN: 0261-3166
DOI: 10.1093/nass/nrn331

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant antibody toxins specific for

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e

Redefining prognostic factors for breast

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

✍ Golareh Habibi, Samuel Leung, Jennifer H Law, Karen Gelmon… 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 953 KB

Synthesis, Biochemical Properties and Mo

Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone-Dependent and Hormone-Independent Breast Cancer Cell Lines

✍ Siden Top; Anne Vessières; Guy Leclercq; Jacques Quivy; J. Tang; J. Vaissermann; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB 👁 2 views

## Abstract A series of ferrocene derivatives based upon the structure of the antiestrogenic drug tamoxifen or of its active metabolite hydroxytamoxifen has been prepared and named by analogy ferrocifens and hydroxyferrocifens. This series includes 1‐[4‐(O(CH~2~)~__n__~NMe~2~)phenyl]‐1‐phenyl‐2‐fer